CorMedix Inc. (CRMD) › Capital ExpendituresCorMedix Inc. (CRMD) — Capital ExpendituresAnnual figures by period end, from SEC filings.2010-12-31: $10.4K2011-12-31: $1.6K2012-12-31: $02013-12-31: $35.7K2014-12-31: $25.4K2015-12-31: $15.4K2016-12-31: $58.7K2017-12-31: $152.0K2018-12-31: $48.9K2019-12-31: $36.6K2020-12-31: $112.6K2021-12-31: $1.43M2022-12-31: $219.4K2023-12-31: $327.3K2024-12-31: $116.0K2025-12-31: $2.26M$2.26M2010-12-31Capital Expenditures (USD)2025-12-31Period endedCapital ExpendituresChange YoYSource filing2025-12-31$2.26M+1848.3%2026-03-05From 2025-01-012024-12-31$116.0K-64.6%2026-03-05From 2024-01-012023-12-31$327.3K+49.2%2025-03-25From 2023-01-012022-12-31$219.4K-84.6%2024-03-12From 2022-01-012021-12-31$1.43M+1165.4%2023-03-30From 2021-01-012020-12-31$112.6K+208.0%2022-03-29From 2020-01-012019-12-31$36.6K-25.2%2021-03-30From 2019-01-012018-12-31$48.9K-67.8%2020-03-16From 2018-01-012017-12-31$152.0K+158.8%2019-05-29From 2017-01-012016-12-31$58.7K+280.2%2018-03-19From 2016-01-012015-12-31$15.4K-39.2%2017-03-16From 2015-01-012014-12-31$25.4K-28.8%2017-03-16From 2014-01-012013-12-31$35.7K—2015-03-12From 2013-01-012012-12-31$0-100.0%2014-03-31From 2012-01-012011-12-31$1.6K-84.3%2014-03-04From 2011-01-012010-12-31$10.4K—2012-04-26From 2010-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)